MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1164/rccm.200909-1367oc

Медицинская библиотека · American journal of respiratory and critical care medicine · 2010

Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension.

Hecker Matthias, Zaslona Zbigniew, Kwapiszewska Grazyna, Niess Gero, Zakrzewicz Anna, Hergenreider Eduard, Wilhelm Jochen, Marsh Leigh M, Sedding Daniel, Klepetko Walter, Lohmeyer Jürgen, Dimmeler Stefanie, Seeger Werner, Weissmann Norbert, Schermuly Ralph T, Kneidinger Nikolaus, Eickelberg Oliver, Morty Rory E

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

RATIONALE: Idiopathic pulmonary arterial hypertension (IPAH) is characterized by medial hypertrophy due to pulmonary artery smooth muscle cell (paSMC) hyperplasia. Inflammation is proposed to play a role in vessel remodeling associated with IPAH. IL-13 is emerging as a regulator of tissue remodeling; however, the contribution of the IL-13 system to IPAH has not been assessed.

OBJECTIVES

The objective of this study was to assess the possible contribution of the IL-13 system to IPAH.

METHODS

Expression and localization of IL-13, and IL-13 receptors IL-4R, IL-13Rα1, and IL-13Rα2 were assessed by real-time reverse transcription-polymerase chain reaction, immunohistochemistry, and flow cytometry in lung tissue, paSMC, and microdissected vascular lesions from patients with IPAH, and in lung tissue from rodents with hypoxia- or monocrotaline-induced pulmonary hypertension. A whole-genome microarray analysis was used to study IL-13-regulated genes in paSMC.

MEASUREMENTS AND MAIN

RESULTS

Pulmonary expression of the IL-13 decoy receptor IL-13Rα2 was up-regulated relative to that of the IL-13 signaling receptors IL-4R and IL-13Rα1 in patients with IPAH and in two animal models of IPAH. IL-13, signaling via STAT3 and STAT6, suppressed proliferation of paSMC by promoting G(0)/G(1) arrest. Whole-genome microarrays revealed that IL-13 suppressed endothelin-1 production by paSMC, suggesting that IL-13 controlled paSMC growth by regulating endothelin production. Ectopic expression of the il13ra2 gene resulted in partial loss of paSMC growth control by IL-13 and blunted IL-13 suppression of endothelin-1 production by paSMC, whereas small-interfering RNA knockdown of il13ra2 gene expression had the opposite effects.

CONCLUSIONS

The IL-13 system is a novel regulator of paSMC growth. Dysregulation of IL-13 receptor expression in IPAH may partially underlie smooth muscle hypertrophy associated with pathological vascular remodeling in IPAH.

Для цитирования: Hecker Matthias, Zaslona Zbigniew, Kwapiszewska Grazyna, Niess Gero, Zakrzewicz Anna, Hergenreider Eduard, Wilhelm Jochen, Marsh Leigh M, Sedding Daniel, Klepetko Walter, Lohmeyer Jürgen, Dimmeler Stefanie, Seeger Werner, Weissmann Norbert, Schermuly Ralph T, Kneidinger Nikolaus, Eickelberg Oliver, Morty Rory E. Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension.. American journal of respiratory and critical care medicine. 2010. DOI: 10.1164/rccm.200909-1367oc.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.